Health-related quality of life in hereditary hemorrhagic telangiectasia

Otolaryngology - Head and Neck Surgery

Volumn 136, Issue 5, 2007, Pages 726.e1-726.e10

  Geisthoff, Urban W ^a   Heckmann, Katinka ^a   D'Amelio, Roberto ^a   Grünewald, Stefan ^a   Knöbber, Dirk ^a   Falkai, Peter ^a   König, Jochem ^b  

^a SAARLAND UNIVERSITY   (Germany)

^b Epidemiology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE DURATION; EPISTAXIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; QUESTIONNAIRE; RENDU OSLER WEBER DISEASE; SCORING SYSTEM; SHORT FORM 36; TERTIARY HEALTH CARE;

EID: 34247519602     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2006.12.019     Document Type: Article

References (18)

1. Guttmacher A.E., Marchuk D.A., and White Jr. R.I. Hereditary hemorrhagic telangiectasia. N Engl J Med 333 14 (1995) 918-924
2. Shovlin C.L., Guttmacher A.E., Buscarini E., et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91 1 (2000) 66-67
3. Geisthoff U.W., Schneider G., Fischinger J., et al. Hereditäre hämorrhagische Teleangiektasie (Morbus Osler). Eine interdisziplinäre Herausforderung. HNO 50 2 (2002) 114-128
4. Longacre A.V., Gross C.P., Gallitelli M., et al. Diagnosis and management of gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia. Am J Gastroenterol 98 1 (2003) 59-65
5. White Jr. R.I. Pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia: embolotherapy using balloons and coils. Arch Intern Med 156 22 (1996) 2627-2628
6. Matsubara S., Mandzia J.L., der Brugge K., et al. Angiographic and clinical characteristics of patients with cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia. AJNR Am J Neuroradiol 21 6 (2000) 1016-1020
7. Garcia-Tsao G., Korzenik J.R., Young L., et al. Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 343 13 (2000) 931-936
8. Kjeldsen A.D., Vase P., and Green A. Hereditary hemorrhagic telangiectasia. A population-based study on prevalence and mortality among Danish HHT patients [in Danish}. Ugeskr Laeger 162 25 (2000) 3597-3601
9. Lennox P.A., Hitchings A.E., Lund V.J., et al. The SF-36 health status questionnaire in assessing patients with epistaxis secondary to hereditary hemorrhagic telangiectasia. Am J Rhinol 19 1 (2005) 71-74
10. Pasculli G., Resta F., Guastamacchia E., et al. Health-related quality of life in a rare disease: hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler-Weber disease. Qual Life Res 13 10 (2004) 1715-1723
11. Karapantzos I., Tsimpiris N., Goulis D.G., et al. Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:YAG laser and quality of life assessment using the HR-QoL questionnaire. Eur Arch Otorhinolaryngol 262 10 (2005) 830-833
12. Hitchings A.E., Lennox P.A., Lund V.J., et al. The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia. Am J Rhinol 19 1 (2005) 75-78
13. Bullinger M., and Kirchberger I. SF-Fragebogen zum Gesundheitszustand, Handanweisung (1998), Hogrefe Verlag für Psychologie, Göttingen, Bern, Toronto, Seattle
14. Ware J.J., Snowk K., Kosinski M., et al. SF-36 health survey manual and interpretation guide (1993), The Health Institute, New England Medical Center, Boston, MA
15. Garratt A., Schmidt L., Mackintosh A., et al. Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ 324 7351 (2002) 1417
16. Abdalla S.A., Geisthoff U.W., Bonneau D., et al. Visceral manifestations in hereditary haemorrhagic telangiectasia type 2. J Med Genet 40 7 (2003) 494-502
17. Brazier J.E., Harper R., Jones N.M., et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 305 6846 (1992) 160-164
18. Osler W. On a family form of recurring epistaxis, associated with multiple telangiectases of the skin and mucous membranes. Johns Hopkins Hospital Bulletin 12 (1901) 333-337